191 related articles for article (PubMed ID: 17970078)
1. Induction of cell death by combination treatment with cisplatin and 5-fluorouracil in a human oral squamous cell carcinoma cell line.
Okamura M; Kobayashi M; Suzuki F; Shimada J; Sakagami H
Anticancer Res; 2007; 27(5A):3331-7. PubMed ID: 17970078
[TBL] [Abstract][Full Text] [Related]
2. Comparative analysis of cell death induction by cisplatin and 5-FU in human oral squamous and hepatocellular carcinoma cell lines.
Okamura M; Shimada J; Sakagami H
Anticancer Res; 2008; 28(1A):253-9. PubMed ID: 18383853
[TBL] [Abstract][Full Text] [Related]
3. Apoptosis-inducing activity of cisplatin (CDDP) against human hepatoma and oral squamous cell carcinoma cell lines.
Okamura M; Hashimoto K; Shimada J; Sakagami H
Anticancer Res; 2004; 24(2B):655-61. PubMed ID: 15161008
[TBL] [Abstract][Full Text] [Related]
4. Potentiation of induction of apoptosis by sequential treatment with cisplatin followed by 5-fluorouracil in human oral cancer cells.
Azuma M; Harada K; Supriatno ; Tamatani T; Motegi K; Ashida Y; Sato M
Int J Oncol; 2004 Jun; 24(6):1449-55. PubMed ID: 15138587
[TBL] [Abstract][Full Text] [Related]
5. Mechanism(s) of antitumor action in protracted infusion of low dose 5-fluorouracil and cisplatin in gastric carcinoma.
Kim R; Tanabe K; Inoue H; Toge T
Int J Oncol; 2002 Mar; 20(3):549-55. PubMed ID: 11836567
[TBL] [Abstract][Full Text] [Related]
6. Enhancement of cisplatin cytotoxicity by SAHA involves endoplasmic reticulum stress-mediated apoptosis in oral squamous cell carcinoma cells.
Suzuki M; Endo M; Shinohara F; Echigo S; Rikiishi H
Cancer Chemother Pharmacol; 2009 Nov; 64(6):1115-22. PubMed ID: 19280190
[TBL] [Abstract][Full Text] [Related]
7. Induction of non-apoptotic cell death by morphinone in human promyelocytic leukemia HL-60 cells.
Takeuchi R; Hoshijima H; Nagasaka H; Chowdhury SA; Kikuchi H; Kanda Y; Kunii S; Kawase M; Sakagami H
Anticancer Res; 2006; 26(5A):3343-8. PubMed ID: 17094451
[TBL] [Abstract][Full Text] [Related]
8. Re-evaluation of tumor-specific cytotoxicity of mitomycin C, bleomycin and peplomycin.
Sasaki M; Okamura M; Ideo A; Shimada J; Suzuki F; Ishihara M; Kikuchi H; Kanda Y; Kunii S; Sakagami H
Anticancer Res; 2006; 26(5A):3373-80. PubMed ID: 17094455
[TBL] [Abstract][Full Text] [Related]
9. Tumor-specificity and type of cell death induced by trihaloacetylazulenes in human tumor cell lines.
Sekine T; Takahashi J; Nishishiro M; Arai A; Wakabayashi H; Kurihara T; Kobayashi M; Hashimoto K; Kikuchi H; Katayama T; Kanda Y; Kunii S; Motohashi N; Sakagami H
Anticancer Res; 2007; 27(1A):133-43. PubMed ID: 17352225
[TBL] [Abstract][Full Text] [Related]
10. Tumor-specific cytotoxicity and type of cell death induced by sodium 5,6-benzylidene-L-ascorbate.
Kishino K; Hashimoto K; Amano O; Kochi M; Liu WK; Sakagami H
Anticancer Res; 2008; 28(5A):2577-84. PubMed ID: 19035281
[TBL] [Abstract][Full Text] [Related]
11. Influence of treatment sequence on efficacy of fluorouracil and cisplatin intratumoral drug delivery in vivo.
Yu NY; Patawaran MB; Chen JY; Orenberg EK; Brown DM; Luck EE
Cancer J Sci Am; 1995; 1(3):215-21. PubMed ID: 9166479
[TBL] [Abstract][Full Text] [Related]
12. Cytotoxic activity of styrylchromones against human tumor cell lines.
Momoi K; Sugita Y; Ishihara M; Satoh K; Kikuchi H; Hashimoto K; Yokoe I; Nishikawa H; Fujisawa S; Sakagami H
In Vivo; 2005; 19(1):157-63. PubMed ID: 15796168
[TBL] [Abstract][Full Text] [Related]
13. Inhibition by 5-fluorouracil of cis-diamminedichloroplatinum(II)-induced DNA interstrand cross-link removal in a HST-1 human squamous carcinoma cell line.
Esaki T; Nakano S; Tatsumoto T; Kuroki-Migita M; Mitsugi K; Nakamura M; Niho Y
Cancer Res; 1992 Dec; 52(23):6501-6. PubMed ID: 1423296
[TBL] [Abstract][Full Text] [Related]
14. Induction of tumor-specific cytotoxicity and apoptosis by doxorubicin.
Suzuki F; Hashimoto K; Kikuchi H; Nishikawa H; Matsumoto H; Shimada J; Kawase M; Sunaga K; Tsuda T; Satoh K; Sakagami H
Anticancer Res; 2005; 25(2A):887-93. PubMed ID: 15868924
[TBL] [Abstract][Full Text] [Related]
15. [Method for daily administration of low-dose CDDP and 5-FU combined with radiotherapy for oral squamous cell carcinoma].
Kishimoto K; Kimura T; Misaki M; Yamada Y; Terakado N; Matsumura T
Gan To Kagaku Ryoho; 1995 Jan; 22(1):111-4. PubMed ID: 7826064
[TBL] [Abstract][Full Text] [Related]
16. Apoptosis-inducing activity of trihaloacetylazulenes against human oral tumor cell lines.
Akatsu Y; Ohshima N; Yamagishi Y; Nishishiro M; Wakabayashi H; Kurihara T; Kikuchi H; Katayama T; Motohashi N; Shoji Y; Nakashima H; Sakagami H
Anticancer Res; 2006; 26(3A):1917-23. PubMed ID: 16827125
[TBL] [Abstract][Full Text] [Related]
17. Tumor-specific cytotoxicity and apoptosis-inducing activity of berberines.
Inoue K; Kulsum U; Chowdhury SA; Fujisawa S; Ishihara M; Yokoe I; Sakagami H
Anticancer Res; 2005; 25(6B):4053-9. PubMed ID: 16309199
[TBL] [Abstract][Full Text] [Related]
18. Chemosensitization of oral squamous cell carcinoma cells to cisplatin by histone deacetylase inhibitor, suberoylanilide hydroxamic acid.
Rikiishi H; Shinohara F; Sato T; Sato Y; Suzuki M; Echigo S
Int J Oncol; 2007 May; 30(5):1181-8. PubMed ID: 17390020
[TBL] [Abstract][Full Text] [Related]
19. Involvement of caspases in 5-FU induced apoptosis in an oral cancer cell line.
Ohtani T; Hatori M; Ito H; Takizawa K; Kamijo R; Nagumo M
Anticancer Res; 2000; 20(5A):3117-21. PubMed ID: 11062731
[TBL] [Abstract][Full Text] [Related]
20. Enhanced antitumor efficacy of nedaplatin with 5-fluorouracil against human squamous carcinoma xenografts.
Takeda Y; Kasai H; Uchida N; Yoshida H; Maekawa R; Sugita K; Yoshioka T
Anticancer Res; 1999; 19(5B):4059-64. PubMed ID: 10628354
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
